RGA
GSK icon

Red Granite Advisors’s GSK GSK Stock Holding History

Red Granite Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$1.28M Sell
20,471
-1,000
-5% -$64.4K 0.28% 41
2013
Q2 		$1.34M Buy
+21,471
New +$1.36M 0.33% 41

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Red Granite Advisors's GSK Position: Q3 2013 in Review

Red Granite Advisors reduced its GSK (GSK) stake by 4.7% in Q3 2013, selling an estimated $64.4K and leaving 20,471 shares worth $1.28M. The position accounts for 0.28% of the portfolio, ranked #41.

Red Granite Advisors first reported a position in GSK in Q2 2013 and has held it in 2 quarters since. The position peaked at $1.34M in Q2 2013. 635 funds tracked by Wall St. Rank hold GSK as of Q3 2013.

  • Red Granite Advisors held 20,471 shares of GSK worth $1.28M as of Q3 2013.
  • Red Granite Advisors sold 1,000 GSK shares in Q3 2013, an estimated $64.4K.
  • GSK made up 0.28% of Red Granite Advisors's portfolio in Q3 2013, its #41 holding.
  • Red Granite Advisors first reported a position in GSK in Q2 2013 and has held it in 2 quarters since.
  • Red Granite Advisors's GSK position peaked at $1.34M in Q2 2013.
  • 635 funds tracked by Wall St. Rank held GSK as of Q3 2013.

Based on Red Granite Advisors's 13F filing for Q3 2013, filed 6 Nov 2013.